doi: 10.1038/nrc2715 131 VuralG.GumusyaylaS.BektasH.DenizO.AlisikM.ErelO
Why the Third Hormone Matters: Metabolic Impact The inclusion of glucagon agonism is what makes the retatrutide vs tirzepatide comparison so compelling from a functional and anti-aging perspective
When using GLP-1 medications, certain foods and eating habits should be minimized or avoided because they may reduce treatment benefits, increase side effects, contribute to poor nutrition, interfere with blood sugar control, or affect healthy weight reduction
The manic-depressive spectrum Manic-Depressive Illness Oxford University Press: New York 1990
For people aged 18-29, only 1% had ever used GLP-1 drugs to treat chronic conditions, while 7% of those in this age group had used them for weight loss, and a further 3% had used them for chronic conditions and weight loss